Viewing Study NCT00770432


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-01-01 @ 7:31 AM
Study NCT ID: NCT00770432
Status: COMPLETED
Last Update Posted: 2018-10-02
First Post: 2008-10-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)
Sponsor: Bayer
Organization:

Study Overview

Official Title: A Randomized, Placebo-Controlled, Double-Blind, Trial of Polyethylene Glycol 3350 Laxative for the Treatment of Occasional Constipation.
Status: COMPLETED
Status Verified Date: 2018-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Randomized, placebo-controlled, double blind study. 203 subjects entered the study to compare the effect on occasional constipation of polyethylene glycol 3350 to placebo. Subjects took one of study treatments up to 7 days.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
CL2007-12 None None View
P08216 OTHER Merck View